Document is current

Article History

Received: 2 April 2025

Accepted: 15 July 2025

First Online: 5 August 2025

Declarations

:

: Lorena De La Mora has received fees to give lectures from Gilead, MSD, ViiV, AbbVie and Janssen-Cilag. Montserrat Laguno has received fees to give lectures from Gilead, MSD, ViiV, AbbVie and Janssen-Cilag. Maria Martínez-Rebollar has received fees to give lectures from Gilead, MSD, ViiV, AbbVie and Janssen-Cilag. Berta Torres has received fees to give lectures from Gilead, MSD, ViiV, AbbVie and Janssen-Cilag. Juan Amborsioni has participated in advisory boards and received consulting honoraria, research grants, or both from Gilead Sciences, Janssen Pharmaceuticals, and ViiV Healthcare, all outside of this work. Alberto Foncillas has received fees to give lectures from Gilead and ViiV. Esteban Martínez has received honoraria for lectures or advisory boards from Gilead and Janssen, and his institution has received research grants from MSD and ViiV. Laia Miquel has received honoraria for lectures from Lundbeck, Gilead and Neuraxpharm. Jordi Blanch has received honoraria for lectures or advisory boards from Ferrer Internacional, Gilead, Janssen, MSD and ViiV. Ana González-Cordón has received fees to give lectures and participate in advisory boards from Gilead, MSD, ViiV, AbbVie and Janssen-Cilag. Alexy Inciarte has received educational grants from MSD and Gilead. José Luís Blanco has received honoraria for lectures or advisory boards from Gilead, Janssen, MSD. Iván Chivite has received fees to give lectures from Gilead, MSD, ViiV, AbbVie and Janssen-Cilag. Duncan Short is an employee of ViiV Healthcare and a shareholder of GlaxoSmithKline. Josep Mallolas has received honoraria, speakers’ fees, consultant fees or funds for research from MSD, Roche, Boehringer-Ingelheim, ViiV, Gilead, Janssen, BMS, and AbbVie. Estela Solbes has a research grant from Gilead. Elisa De Lazzari, Leire Berrocal, Ana Rodriguez, Pilar Callau, Júlia Calvo and Rubén Mora have nothing to disclose. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

: The present study adhered to the ethical principles set forth in the Declaration of Helsinki from 1964 and its later amendments and followed all principles of good clinical practice. Ethics approval was previously obtained from the local research ethics committee from Hospital Clínic of Barcelona for the CSC Study (HCB/2017/0909) and funded by an international grant from ViiV Healthcare through its Positive Pathways program. All participants signed an informed consent form consenting to the study and further use of data.